-
Je něco špatně v tomto záznamu ?
Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group
LC. Verbruggen, Y. Wang, SH. Armenian, MJ. Ehrhardt, HJH. van der Pal, EC. van Dalen, JW. van As, E. Bardi, K. Baust, C. Berger, E. Castagnola, KA. Devine, J. Gebauer, JG. Marchak, AW. Glaser, AH. Groll, GM. Haeusler, J. den Hartogh, R. Haupt, L....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie
PubMed
32969160
DOI
10.1002/pbc.28702
Knihovny.cz E-zdroje
- MeSH
- Betacoronavirus * MeSH
- COVID-19 MeSH
- dítě MeSH
- dospělí MeSH
- koronavirové infekce epidemiologie prevence a kontrola terapie přenos MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- nádory epidemiologie terapie MeSH
- pandemie prevence a kontrola MeSH
- předškolní dítě MeSH
- přežívající onkologičtí pacienti * MeSH
- SARS-CoV-2 MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- virová pneumonie epidemiologie prevence a kontrola terapie přenos MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.
Cochrane Childhood Cancer Amsterdam the Netherlands
Department for Pediatric Hematology and Oncology University Hospital Bonn Bonn Germany
Department of Health Sciences and Medicine University of Lucerne Lucerne Switzerland
Department of Malignant Haematology Great Ormond Street Hospital for Children NHS Trust London UK
Department of Oncology Division of Psychosocial Oncology University of Calgary Calgary AB Canada
Department of Pediatric Hematology and Oncology University Hospitals Leuven Leuven Belgium
Department of Pediatrics Nippon Medical School Tokyo Japan
Department of Population Sciences City of Hope National Medical Center Duarte California USA
Division of Haematology Oncology The Hospital for Sick Children Toronto Canada
Emory University School of Medicine Aflac Cancer and Blood Disorders Center Atlanta Georgia USA
Epidemiology and Biostatistics Unit and DOPO clinic IRCCS Istituto Giannina Gaslini Genova Italy
Epidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini Genova Italy
Infectious Diseases Unit IRCCS Istituto Giannina Gaslini Genova Italy
Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands
St Anna Childrens Hospital Vienna Austria Kepler University Clinic Med Campus 4 Linz Austria
St Luke's International University Tokyo Japan
The Hospital for Sick Children Toronto Canada
University Hospital Brno and St Anna University Hospital ICRC Masaryk University Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20027618
- 003
- CZ-PrNML
- 005
- 20210114152134.0
- 007
- ta
- 008
- 210105s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/pbc.28702 $2 doi
- 035 __
- $a (PubMed)32969160
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Verbruggen, Lisanne C $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- 245 10
- $a Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group / $c LC. Verbruggen, Y. Wang, SH. Armenian, MJ. Ehrhardt, HJH. van der Pal, EC. van Dalen, JW. van As, E. Bardi, K. Baust, C. Berger, E. Castagnola, KA. Devine, J. Gebauer, JG. Marchak, AW. Glaser, AH. Groll, GM. Haeusler, J. den Hartogh, R. Haupt, L. Hjorth, M. Kato, T. Kepák, MMWR. Koopman, T. Langer, M. Maeda, G. Michel, M. Muraca, PC. Nathan, SR. van den Oever, V. Pavasovic, S. Sato, F. Schulte, L. Sung, W. Tissing, A. Uyttebroeck, RL. Mulder, C. Kuehni, R. Skinner, MM. Hudson, LCM. Kremer,
- 520 9_
- $a Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a Betacoronavirus $7 D000073640
- 650 _2
- $a COVID-19 $7 D000086382
- 650 12
- $a přežívající onkologičtí pacienti $7 D000073116
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a koronavirové infekce $x epidemiologie $x prevence a kontrola $x terapie $x přenos $7 D018352
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nádory $x epidemiologie $x terapie $7 D009369
- 650 _2
- $a pandemie $x prevence a kontrola $7 D058873
- 650 _2
- $a virová pneumonie $x epidemiologie $x prevence a kontrola $x terapie $x přenos $7 D011024
- 650 _2
- $a směrnice pro lékařskou praxi jako téma $7 D017410
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Wang, Yuehan $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- 700 1_
- $a Armenian, Saro H $u Department of Population Sciences, City of Hope National Medical Center, Duarte, California, USA.
- 700 1_
- $a Ehrhardt, Matthew J $u Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- 700 1_
- $a van der Pal, Helena J H $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- 700 1_
- $a van Dalen, Elvira C $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- 700 1_
- $a van As, Jorrit W $u Cochrane Childhood Cancer, Amsterdam, the Netherlands.
- 700 1_
- $a Bardi, Edit $u St Anna Childrens Hospital, Vienna, Austria. Kepler University Clinic, Med Campus IV, Linz, Austria.
- 700 1_
- $a Baust, Katja $u Department for Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
- 700 1_
- $a Berger, Claire $u Department for Pediatric Hematology and Oncology CHU Nord, University Hospital Saint-Etienne, Saint-Priest en Jarez, France. Epidemiology of Childhood and Adolescent Cancers, CRESS, INSERM, UMR 1153, Paris Descartes University, Villejuif, France.
- 700 1_
- $a Castagnola, Elio $u Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
- 700 1_
- $a Devine, Katie A $u Rutgers Cancer Institute of New Jersey, The State University of New Jersey, New Brunswick, New Jersey, USA.
- 700 1_
- $a Gebauer, Judith $u Institute for Endocrinology and Diabetes, University of Luebeck, Ratzeburger Allee 160, Luebeck, 23562, Germany.
- 700 1_
- $a Marchak, Jordan Gilleland $u Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, Georgia, USA.
- 700 1_
- $a Glaser, Adam W $u Department of Paediatric Oncology, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT, UK.
- 700 1_
- $a Groll, Andreas H $u Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology University Children's Hospital, Münster, Germany.
- 700 1_
- $a Haeusler, Gabrielle M $u NHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. Department of Infectious Diseases, Peter MacCallum Cancer Centre and Royal Children's Hospital, Parkville, Victoria, Australia. Murdoch Children's Research Institute, Parkville, Victoria, Australia.
- 700 1_
- $a den Hartogh, Jaap $u Dutch Childhood Cancer Parent Organization VOKK Netherlands, Department VOX Survivors, Nieuwegein, the Netherlands.
- 700 1_
- $a Haupt, Riccardo $u Epidemiology and Biostatistics Unit and DOPO clinic IRCCS Istituto Giannina Gaslini, Genova, Italy.
- 700 1_
- $a Hjorth, Lars $u Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Pediatrics, Lund, Sweden.
- 700 1_
- $a Kato, Miho $u Department of Pediatric Hematology/Oncology, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center, Okinawa, Japan.
- 700 1_
- $a Kepák, Tomáš $u University Hospital Brno and St. Anna University Hospital/ICRC, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Koopman, Maria M W Rianne $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- 700 1_
- $a Langer, Thorsten $u University Hospital for Children and Adolescents, Pediatric Oncology and Hematology, Ratzeburger Allee 160, Luebeck, 23562, Germany.
- 700 1_
- $a Maeda, Miho $u Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
- 700 1_
- $a Michel, Gisela $u Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
- 700 1_
- $a Muraca, Monica $u Epidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini, Genova, Italy.
- 700 1_
- $a Nathan, Paul C $u The Hospital for Sick Children, Toronto, Canada.
- 700 1_
- $a van den Oever, Selina R $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- 700 1_
- $a Pavasovic, Vesna $u Department of Malignant Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
- 700 1_
- $a Sato, Satomi $u St. Luke's International University, Tokyo, Japan.
- 700 1_
- $a Schulte, Fiona $u Department of Oncology, Division of Psychosocial Oncology, University of Calgary, Calgary, AB, Canada.
- 700 1_
- $a Sung, Lillian $u Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.
- 700 1_
- $a Tissing, Wim $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- 700 1_
- $a Uyttebroeck, Anne $u Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium.
- 700 1_
- $a Mulder, Renée L $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- 700 1_
- $a Kuehni, Claudia $u Childhood Cancer Registry (ChCR), Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.
- 700 1_
- $a Skinner, Roderick $u Department of Paediatric and Adolescent Haematology/Oncology, Great North Children's Hospital, and Clinical and Translational Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
- 700 1_
- $a Hudson, Melissa M $u Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- 700 1_
- $a Kremer, Leontien C M $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Amsterdam University Medical Center, Department of Pediatrics, Amsterdam, the Netherlands.
- 773 0_
- $w MED00181047 $t Pediatric blood & cancer $x 1545-5017 $g Roč. 67, č. 12 (2020), s. e28702
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32969160 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114152132 $b ABA008
- 999 __
- $a ok $b bmc $g 1607953 $s 1118798
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 67 $c 12 $d e28702 $e 20200923 $i 1545-5017 $m Pediatric blood & cancer $n Pediatr Blood Cancer $x MED00181047
- LZP __
- $a Pubmed-20210105
